Janus Kinase Inhibitors as first line therapeutic option in atopic dermatitis: a selection of phenotypes to start from

JAK inhibitors (JAKi) have shown high efficacy and rapidity in solving skin lesions and itching, in moderate to severe atopic dermatitis (AD). Althoug...